vs

Side-by-side financial comparison of NovoCure Ltd (NVCR) and Palomar Holdings, Inc. (PLMR). Click either name above to swap in a different company.

Palomar Holdings, Inc. is the larger business by last-quarter revenue ($253.4M vs $174.3M, roughly 1.5× NovoCure Ltd). On growth, Palomar Holdings, Inc. posted the faster year-over-year revenue change (62.7% vs 8.1%). Palomar Holdings, Inc. produced more free cash flow last quarter ($409.0M vs $-22.9M). Over the past eight quarters, Palomar Holdings, Inc.'s revenue compounded faster (46.2% CAGR vs 12.2%).

NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.

Palomar Holdings, Inc. is a specialty insurance holding company that primarily provides property insurance products for catastrophe-exposed residential and commercial assets. It mainly operates across the United States, focusing on core segments including earthquake, flood, and windstorm coverage to meet high-risk property protection demands of customers.

NVCR vs PLMR — Head-to-Head

Bigger by revenue
PLMR
PLMR
1.5× larger
PLMR
$253.4M
$174.3M
NVCR
Growing faster (revenue YoY)
PLMR
PLMR
+54.6% gap
PLMR
62.7%
8.1%
NVCR
More free cash flow
PLMR
PLMR
$431.9M more FCF
PLMR
$409.0M
$-22.9M
NVCR
Faster 2-yr revenue CAGR
PLMR
PLMR
Annualised
PLMR
46.2%
12.2%
NVCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NVCR
NVCR
PLMR
PLMR
Revenue
$174.3M
$253.4M
Net Profit
$-24.5M
Gross Margin
75.8%
Operating Margin
-23.2%
28.7%
Net Margin
-14.1%
Revenue YoY
8.1%
62.7%
Net Profit YoY
62.8%
EPS (diluted)
$-0.22
$2.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NVCR
NVCR
PLMR
PLMR
Q4 25
$174.3M
$253.4M
Q3 25
$167.2M
$244.7M
Q2 25
$158.8M
$203.3M
Q1 25
$155.0M
$174.6M
Q4 24
$161.3M
$155.8M
Q3 24
$155.1M
$148.5M
Q2 24
$150.4M
$131.1M
Q1 24
$138.5M
$118.5M
Net Profit
NVCR
NVCR
PLMR
PLMR
Q4 25
$-24.5M
Q3 25
$-37.3M
$51.5M
Q2 25
$-40.1M
$46.5M
Q1 25
$-34.3M
$42.9M
Q4 24
$-65.9M
Q3 24
$-30.6M
$30.5M
Q2 24
$-33.4M
$25.7M
Q1 24
$-38.8M
$26.4M
Gross Margin
NVCR
NVCR
PLMR
PLMR
Q4 25
75.8%
Q3 25
73.2%
Q2 25
73.9%
Q1 25
75.1%
Q4 24
79.2%
Q3 24
77.2%
Q2 24
77.0%
Q1 24
75.7%
Operating Margin
NVCR
NVCR
PLMR
PLMR
Q4 25
-23.2%
28.7%
Q3 25
-21.5%
27.4%
Q2 25
-24.9%
29.5%
Q1 25
-24.4%
30.8%
Q4 24
-39.3%
28.9%
Q3 24
-20.7%
25.9%
Q2 24
-22.3%
25.5%
Q1 24
-30.0%
29.0%
Net Margin
NVCR
NVCR
PLMR
PLMR
Q4 25
-14.1%
Q3 25
-22.3%
21.0%
Q2 25
-25.3%
22.9%
Q1 25
-22.1%
24.6%
Q4 24
-40.9%
Q3 24
-19.7%
20.5%
Q2 24
-22.2%
19.6%
Q1 24
-28.0%
22.3%
EPS (diluted)
NVCR
NVCR
PLMR
PLMR
Q4 25
$-0.22
$2.05
Q3 25
$-0.33
$1.87
Q2 25
$-0.36
$1.68
Q1 25
$-0.31
$1.57
Q4 24
$-0.61
$1.29
Q3 24
$-0.28
$1.15
Q2 24
$-0.31
$1.00
Q1 24
$-0.36
$1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NVCR
NVCR
PLMR
PLMR
Cash + ST InvestmentsLiquidity on hand
$93.5M
$106.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$340.5M
$942.7M
Total Assets
$804.3M
$3.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NVCR
NVCR
PLMR
PLMR
Q4 25
$93.5M
$106.9M
Q3 25
$342.1M
$111.7M
Q2 25
$149.6M
$81.3M
Q1 25
$127.3M
$119.3M
Q4 24
$163.8M
$80.4M
Q3 24
$185.4M
$86.5M
Q2 24
$164.8M
$47.8M
Q1 24
$453.8M
$61.4M
Stockholders' Equity
NVCR
NVCR
PLMR
PLMR
Q4 25
$340.5M
$942.7M
Q3 25
$341.3M
$878.1M
Q2 25
$349.4M
$847.2M
Q1 25
$362.0M
$790.4M
Q4 24
$360.2M
$729.0M
Q3 24
$360.8M
$703.3M
Q2 24
$361.8M
$532.6M
Q1 24
$359.4M
$501.7M
Total Assets
NVCR
NVCR
PLMR
PLMR
Q4 25
$804.3M
$3.1B
Q3 25
$1.4B
$2.9B
Q2 25
$1.2B
$2.8B
Q1 25
$1.2B
$2.4B
Q4 24
$1.2B
$2.3B
Q3 24
$1.2B
$2.3B
Q2 24
$1.2B
$2.0B
Q1 24
$1.1B
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NVCR
NVCR
PLMR
PLMR
Operating Cash FlowLast quarter
$-18.0M
$409.1M
Free Cash FlowOCF − Capex
$-22.9M
$409.0M
FCF MarginFCF / Revenue
-13.1%
161.4%
Capex IntensityCapex / Revenue
2.8%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-75.7M
$700.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NVCR
NVCR
PLMR
PLMR
Q4 25
$-18.0M
$409.1M
Q3 25
$20.6M
$83.6M
Q2 25
$-15.9M
$120.9M
Q1 25
$-35.7M
$87.2M
Q4 24
$-3.5M
$261.2M
Q3 24
$10.4M
$100.3M
Q2 24
$-1.7M
$55.1M
Q1 24
$-31.6M
$33.1M
Free Cash Flow
NVCR
NVCR
PLMR
PLMR
Q4 25
$-22.9M
$409.0M
Q3 25
$14.9M
$83.6M
Q2 25
$-21.4M
$120.8M
Q1 25
$-46.3M
$87.1M
Q4 24
$-12.4M
$260.9M
Q3 24
$-307.0K
$100.1M
Q2 24
$-13.2M
Q1 24
$-43.4M
FCF Margin
NVCR
NVCR
PLMR
PLMR
Q4 25
-13.1%
161.4%
Q3 25
8.9%
34.2%
Q2 25
-13.5%
59.4%
Q1 25
-29.9%
49.9%
Q4 24
-7.7%
167.5%
Q3 24
-0.2%
67.4%
Q2 24
-8.8%
Q1 24
-31.3%
Capex Intensity
NVCR
NVCR
PLMR
PLMR
Q4 25
2.8%
0.1%
Q3 25
3.4%
0.0%
Q2 25
3.5%
0.0%
Q1 25
6.8%
0.0%
Q4 24
5.5%
0.2%
Q3 24
6.9%
0.1%
Q2 24
7.6%
0.0%
Q1 24
8.5%
0.0%
Cash Conversion
NVCR
NVCR
PLMR
PLMR
Q4 25
Q3 25
1.63×
Q2 25
2.60×
Q1 25
2.03×
Q4 24
Q3 24
3.29×
Q2 24
2.14×
Q1 24
1.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons